key: cord-0963587-76fu3n5g
authors: Pathak, Kavya; Kadakia, Kushal; Offodile, Anaeze C.; Orgill, Dennis P.
title: Applying Lessons from COVID-19 to Cost Centers across the Phases of Surgical Care
date: 2022-03-22
journal: Plast Reconstr Surg Glob Open
DOI: 10.1097/gox.0000000000004187
sha: d30770b82ceffb107b2fa7ad5c845e7ac59a8ad8
doc_id: 963587
cord_uid: 76fu3n5g

The financial impact of the COVID-19 pandemic has been particularly significant in surgical specialties, with an estimated loss of $22 billion due to deferrals and cancelations of procedures. Evidence suggests that alternative payment models may have reduced the financial impact of COVID-19 for some providers; however, representation of plastic surgery in these models has historically been limited. It is critical for plastic surgeons to understand cost drivers throughout the surgical care episode to design strategies to reduce costs in the wake of the COVID-19 pandemic. In this perspective, we use the American College of Surgeons Five Phases of Surgical Care framework to examine inflationary spending pressures at each stage of the surgical continuum of care. We then highlight cost-containment strategies relevant to plastic and reconstructive surgery within these stages, including those developed before the COVID-19 pandemic, such as bundled payment models and utilization of ambulatory surgery centers, and others expanded during the pandemic, including further use of telemedicine for pre and postoperative visits and expansion of enhanced recovery after surgery pathways and home-based rehabilitation for breast reconstruction. Using innovations from the COVID-19 pandemic can help plastic surgeons further innovate to decrease costs and improve outcomes for patients.

The financial impact of the COVID-19 pandemic has been particularly significant in surgical specialties, with an estimated loss of $22 billion due to deferrals and cancelations of procedures. Evidence suggests that alternative payment models may have reduced the financial impact of COVID-19 for some providers; however, representation of plastic surgery in these models has historically been limited. It is critical for plastic surgeons to understand cost drivers throughout the surgical care episode to design strategies to reduce costs in the wake of the COVID-19 pandemic. In this perspective, we use the American College of Surgeons Five Phases of Surgical Care framework to examine inflationary spending pressures at each stage of the surgical continuum of care. We then highlight cost-containment strategies relevant to plastic and reconstructive surgery within these stages, including those developed before the COVID-19 pandemic, such as bundled payment models and utilization of ambulatory surgery centers, and others expanded during the pandemic, including further use of telemedicine for pre and postoperative visits and expansion of enhanced recovery after surgery pathways and home-based rehabilitation for breast reconstruction. Using innovations from the COVID-19 pandemic can help plastic surgeons further innovate to decrease costs and improve outcomes for patients. 

The American College of Surgeons's five phases model offers an approach for segmenting the distinct processes at each step of care delivery. Figure 1 presents examples of different costs within each of the five phases, and highlights a cost-containment strategy based on the surgical field's experience during COVID-19.

Within the preoperative period, the most significant cost driver in this phase is the decision to operate. Current payment models are based on case volume, incentivizing surgeons to operate more frequently. In contrast, alternative payment models, in which components of a care episode are combined into bundles, have been shown to reduce overall episode costs 4 without a compensatory increase in overall case volume. Within plastic surgery, possible candidates for procedure-based bundles may include repair of distal radius fractures and breast reconstruction. 3 Although considerations remain in defining components of bundles for plastic surgery procedures, this strategy may help curtail costs. The financial impact of COVID-19 may further incentivize payers to adopt procedure-based payment models for more types of surgical procedures.

In the perioperative period, patients meet with various care providers before the procedure. During the pandemic, Medicare payment reforms enabled a rapid transition from in-person office visits to telemedicine. In surgery, telemedicine has been used for multimodal prehabilitation, including physical therapy and nutritional support. 5 Although the cost-savings associated with telemedicine have been appeared minimal due to significant upfront capital investment, there are still savings at the patient and payor level driven by reduced patient travel, telemedicine triage, and remote patient monitoring. 6 Further expansion of telemedicine services through the perioperative period has the potential to contribute to cost savings.

During the intraoperative period, important mediators of procedure cost include facility fees determined by the site of service. Site-of-service optimization for cost management is increasingly common, and many cosmetic surgical procedures are now performed in outpatient settings. When controlling for procedure type, procedures performed at ambulatory surgical centers were cheaper and faster than those performed in-hospital outpatient departments, leading to an estimated savings of $363-$1000 per case. 7 Safety comparisons between hospitals and accredited outpatient locations have not shown differences in adverse event rates, 8 demonstrating that ambulatory surgical centers and offices can be safe alternatives to hospitals. Although limitations exist, including limited regulation of office-based procedure sites and challenges posed by patient comorbidities, 8 identifying additional plastic surgery procedures that can be safely performed in ambulatory surgical centers and offices has the potential to induce cost savings.

After procedure completion, patients move into the postoperative phase, which encompasses immediate inhospital recovery. A crucial driver of total admission cost is the length of hospital stay after a procedure. While ERAS protocols span the continuum of care, the resulting cost savings are primarily generated during the postoperative phase through reductions in length of stay. A review of ERAS implementation in breast reconstruction found a significant decrease in length of stay compared with traditional care. 9 Additionally, the use of ERAS pathways in bilateral mastectomy with immediate implantbased reconstruction has enabled same-day discharge Takeaways Question: How can cost-saving measures deployed before and during the COVID-19 pandemic be used to reduce costs in the surgical episode of care within plastic surgery?

The five phases of surgical care each contain opportunities for cost savings that are relevant to plastic surgery.

Meaning: Plastic surgeons can use the five phases framework to segment surgical costs and understand where savings may be derived. during the pandemic, further decreasing length of stay. Further utilization of ERAS protocols may provide an opportunity to decrease costs for common plastic surgery procedures.

The postdischarge period comprises facility-or home-based postacute care and follow-up visits. Site-ofservice again has important cost ramifications, as postacute care facilities are significantly more expensive than discharging patients to their homes. New options from CMS for "Hospital at Home" programs offer a more robust framework for at-home rehabilitation. For example, Penn Medicine's Connected Approach to Recovery program leveraged digital tools to augment home-based postoperative care for breast reconstruction. 10 As Hospital at Home models expand to cover more surgical conditions, the accessibility of home discharges may create a more patient-centered care paradigm and reduce costs.

The COVID-19 pandemic has placed unprecedented pressures on health systems, and procedure-based specialties have been significantly impacted by shutdowns and cancelation of elective procedures. However, despite these challenges, it has also resulted in opportunities for innovation. By examining cost drivers across the phases of surgical care, plastic surgeons can contribute to the creation of long-term strategies that provide value to patients while controlling costs.

The cost of quarantine: projecting the financial impact of canceled elective surgery on the nation's hospitals

Conceptual considerations for payment bundling in breast reconstruction

ACS comments to the request for information regarding implementation of the merit-based incentive payment system, promotion of alternative payment models, and incentive payments for participation in eligible alternative payment models

The impact of bundled payment on health care spending, utilization, and quality: a systematic review

Prehabilitation telemedicine in neoadjuvant surgical oncology patients during the novel COVID-19 coronavirus pandemic

Determining if telehealth can reduce health system costs: scoping review

Procedures take less time at ambulatory surgery centers, keeping costs down and ability to meet demand up

Is office-based surgery safe? Comparing outcomes of 183,914 aesthetic surgical procedures across different types of accredited facilities

Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature

How Penn Medicine reimagined breast reconstruction, shifting the balance of postoperative care from clinic to home